NIH-funded research R01 grant

Alzheimer's disease and cancer immunity: how mitochondrial lipids in T-cells affect aging-related cancer control

Official title: Determining the Link Between Alzheimer's Disease and Improved Anti-Cancer Immunity via Regulation of Mitochondrial Ceramide Metabolism in T-Cells

Funded at Medical University of South Carolina · NIH-11441839 · Data updated 2026-11-12

This grant explores how changes in mitochondria and lipid metabolism in T-cells of people with Alzheimer's disease might boost or hinder cancer immunity as we age.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMedical University of South Carolina
NIH-funded
Lab location1 site (Charleston, United States)
Project startSeptember 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$443,940
NIH project number1R01AG104132-01
Project IDNIH-11441839 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with Alzheimer's disease or older adults at risk for cancer who may donate blood or immune cells for research.

Less likely to help

People without Alzheimer's disease or not involved in immune studies are unlikely to benefit directly.

What this research studies

If you have Alzheimer's disease or age-related cancer risk, this project looks at why AD patients sometimes show different cancer patterns. Researchers will study how amyloid-related changes in mitochondria influence ceramide signals in T-cells and how that affects their ability to fight cancer. The work uses patient-related samples and cellular models to connect brain disease biology with immune cell function. The goal is to uncover mechanisms that could lead to new treatments that support good immune responses against cancer in aging individuals. Results could point to strategies that improve T-cell energy and anti-tumor activity.

Why it matters

Potential benefit: A better understanding of T-cell metabolism in AD could lead to new ways to boost cancer immunity in older adults.

How similar studies have gone: Preliminary work suggests links between mitochondrial function, ceramide metabolism, and T-cell activity in aging, but this specific AD-cancer immune connection is investigational.

Where this research is happening

  • Medical University of South Carolina
    Charleston, United States
    Active

Researchers

  • Principal investigator: Ogretmen, Besim — Medical University of South Carolina
  • Study coordinator: Ogretmen, Besim

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.